Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals

M Cavic, A Krivokuca, I Boljevic, J Spasic… - Expert review of …, 2021 - Taylor & Francis
ABSTRACT Background: The SARS-CoV-2 pandemic introduced a global distraction effect
in cancer patients' care. The aim of this study was to explore the effect of the pandemic on …

[HTML][HTML] Data-independent acquisition mass spectrometry analysis of FFPE rectal cancer samples offers in-depth proteomics characterization of the response to …

A Stanojevic, M Samiotaki, V Lygirou… - International Journal of …, 2023 - mdpi.com
Locally advanced rectal cancer (LARC) presents a challenge in identifying molecular
markers linked to the response to neoadjuvant chemoradiotherapy (nCRT). This study …

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

M Marinkovic, S Stojanovic-Rundic, A Stanojevic… - Frontiers in …, 2023 - frontiersin.org
Introduction: The standard treatment for locally advanced rectal cancer (LARC) is
neoadjuvant chemoradiotherapy (nCRT). To select patients who would benefit the most from …

Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to …

A Stanojevic, J Spasic, M Marinkovic… - Frontiers in …, 2024 - frontiersin.org
Background: Methylenetetrahydrofolate reductase (MTHFR) single nucleotide
polymorphisms (SNPs) have been suggested as risk, prognostic, and predictive factors for …

[HTML][HTML] Prognostic factors for post-recurrence survival in stage II and III colorectal carcinoma patients

N Nikolic, D Radosavljevic, D Gavrilovic, V Nikolic… - Medicina, 2021 - mdpi.com
Background and objectives: This study aimed to evaluate prognostic factors for post-
recurrence survival in local and locally advanced colorectal cancer patients. Materials and …

Hematological parameters in EGFR-mutated advanced NSCLC patients treated with TKIs: predicting survival and toxicity

V Jokic, K Savic-Vujovic, J Spasic, N Stanic… - Expert Review of …, 2021 - Taylor & Francis
Background: The aim of this study was to analyze the prognostic value of pre-treatment
hematological parameters in EGFR-mutated non-small cell lung cancer patients treated with …

Lung cancer in Serbia

M Cavic, T Kovacevic, B Zaric, D Stojiljkovic… - Journal of Thoracic …, 2022 - jto.org
The Republic of Serbia is located in Central and Southeastern Europe, on the Balkan
Peninsula (Fig. 1). According to official government sources 1, the population of Serbia is …

The value of pharmacogenetics to reduce drug-related toxicity in cancer patients

DZ Mhandire, AKL Goey - Molecular diagnosis & therapy, 2022 - Springer
Many anticancer drugs cause adverse drug reactions (ADRs) that negatively impact safety
and reduce quality of life. The typical narrow therapeutic range and exposure-response …

[HTML][HTML] EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia

M Vukovic, M Tanic, A Damjanovic, M Pavlovic… - Translational …, 2023 - Elsevier
Background The use tumor-derived cell-free DNA extracted from body fluids is being
evaluated for genetic testing in lung cancer. The aim of this study was to explore the …

[HTML][HTML] Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia—Insights from the Institute for Oncology and Radiology of Serbia

M Cavic, N Nikolic, M Marinkovic, A Damjanovic… - Biomedicines, 2024 - mdpi.com
Background: It is projected that, by 2040, the number of new cases of colorectal cancer
(CRC) will increase to 3.2 million, and the number of deaths to 1.6 million, highlighting the …